🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2026-527382-30-00
Terminated Phase I

Bioavailability Comparison of Finerenone 20 mg Tablets (Test vs. Comparator Product).

2026-527382-30-00 · tracked via the Priya Life Science EU tracker
Sponsor
ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
Sponsor type
Pharmaceutical company
Therapeutic area
Cardiovascular Diseases
Decision date
12/08/2026
Enrollment target
52
Sites
Czechia

Condition studied

Comparative bioavailability study under fasting conditions.

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-527382-30-00 on CTIS ↗ ← All trials in the EU